You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMN107A

Showing 1 - 25 of 9,215
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
Has Results
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib

Terminated
Has Results
  • CML
  • +2 more
  • Las Vegas, Nevada
  • +2 more
Apr 28, 2021

Chronic GVHD Trial in Israel, Italy (nilotinib)

Completed
  • Chronic Graft Versus Host Disease
  • Tel Hashomer, Israel
  • +11 more
Aug 19, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 19, 2021

Chronic Myeloid Leukemia Trial in New York (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • New York, New York
    Weill Cornell Medical College
Mar 24, 2022

Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Beirut, Lebanon
    American University of Beirut Medical Center
Feb 14, 2022

Chordoma Trial in Boston (Nilotinib, Radiation therapy)

Active, not recruiting
  • Chordoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 27, 2021

GIST and CML Trial in Worldwide (AMN107)

Active, not recruiting
  • GIST and CML
  • Albany, New York
  • +32 more
Oct 4, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

Not yet recruiting
  • Healthy
  • H107e
  • +10 more
  • Pretoria, Gauteng, South Africa
    Aurum Institute
Sep 24, 2023

Neovascular Age-related Macular Degeneration Trial (AXT107 Low Dose, AXT107 Mid Dose, AXT107 High Dose)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • AXT107 Low Dose
  • +2 more
  • (no location specified)
May 5, 2023

Chronic Myeloid Leukemia Trial in Germany, United Kingdom (Tasigna)

Completed
  • Chronic Myeloid Leukemia
  • Frankfurt/M, Germany
  • +4 more
Dec 6, 2020

Hypertension Trial in Cincinnati (baxdrostat (formerly CIN-107) oral solution)

Completed
  • Hypertension
  • baxdrostat (formerly CIN-107) oral solution
  • Cincinnati, Ohio
    Medpace
Jul 18, 2023

Thrombosis Trial in Perth (SRSD107, Placebo)

Not yet recruiting
  • Thrombosis
  • Perth, Other (Non U.s.), Australia
    Linear Clinical Research
Nov 2, 2023

Advanced Pancreatic Cancer Trial in Shanghai (JS107, JS107 combination with Toripalimab)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • JS107
  • JS107 combination with Toripalimab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 19, 2022

AMN, AMN Gene Mutation, X-ALD Trial in Worcester (SBT101, Imitation Procedure)

Recruiting
  • AMN
  • +2 more
  • SBT101
  • Imitation Procedure
  • Worcester, Massachusetts
    University of Massachusetts Chan Medical School
Jun 1, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) Trial in United States (VK0214, Placebo)

Recruiting
  • Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD)
  • Palo Alto, California
  • +3 more
Jul 19, 2022

Primary Aldosteronism, Hyperaldosteronism Trial in United States (CIN-107 2 mg dosing, CIN-107 4 mg dosing, CIN-107 8 mg dosing)

Recruiting
  • Primary Aldosteronism
  • Hyperaldosteronism
  • CIN-107 2 mg dosing
  • +2 more
  • Los Angeles, California
  • +7 more
Feb 1, 2023

Hypertension Trial in United States (baxdrostat)

Completed
  • Hypertension
  • Rialto, California
  • +4 more
Jul 18, 2023